Cawthorne M A, Arch J R
Int J Obes. 1982;6(1):1-10.
Current pharmacological therapy for the obese patient focuses primarily on centrally acting drugs that affect food intake. At the research level, there is an awareness of the possibility of discovering peripherally acting drugs to modify metabolic processes and thereby create favourable changes in energy balance. Whilst a number of compounds have been shown to be effective as slimming agents in experimental animals, none, as yet, have proved effective in man.
目前针对肥胖患者的药物治疗主要集中在影响食物摄入的中枢作用药物上。在研究层面,人们意识到有可能发现作用于外周的药物来改变代谢过程,从而在能量平衡方面产生有利变化。虽然许多化合物在实验动物中已被证明是有效的减肥剂,但迄今为止,尚无一种在人体中被证明有效。